Publikationen, an denen er mitarbeitet RICARDO LÓPEZ ALMARAZ (1)
2019
-
Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 46, Núm. 7, pp. 1567-1575